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THE BUZZ  
    B E H I N D  
THE BITE
How scientists tackle infectious diseases  
and the mosquitoes that spread them
By Jennifer Tidball
Aedes aegypti mosquito
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 Scott Huang, Dana Vanlandingham and Stephen Higgs study mosquito-transmitted viruses.
THE NUMBERS ARE ENOUGH TO MAKE YOU FEEL ITCHY.
Since 2015, more than 43,000 cases of Zika virus have been reported in U.S. states and 
territories. 
Malaria caused an estimated 212 million clinical cases and 429,000 deaths worldwide 
in 2015.
West Nile virus has infected an estimated 2.5 million people in North America and 
caused more than 44,000 U.S. cases since it emerged in 1999. 
There’s no question: Mosquitoes may be small insects, but their presence affects the 
health of billions of people across the world. 
“Seventy percent of emerging diseases are zoonotic, and many of them are mosquito-
borne,” said Stephen Higgs, director of Kansas State University’s Biosecurity Research 
Institute. “Mosquito-transmitted viruses are expanding. The viruses that Kansas State 
University is working on are things that could be next.”
What’s next? The possible list includes names like Japanese encephalitis virus, yellow 
fever virus or dengue viruses.
No matter the virus and no matter the disease, scientists agree: Advanced research is the 
solution. From studies of viruses, mosquito biology and insect control, Kansas State  
University researchers are tackling the unknowns of infectious diseases and the mosquitoes 
that spread them. They hope to make it easier to manage — and possibly someday  
eradicate — health threats such as malaria or Zika virus.
“Studying these viruses before they get to the United States gives us the knowledge 
we need to prepare,” said Dana Vanlandingham, assistant professor of virology. “It’s 
important to estimate what we think might be coming in, because if it does, we need a 
plan immediately. Debate and slowness let the diseases establish. Once some of these 
diseases are here, they’re here.”
VIRULENCE OF VIRUSES
Researcher Scott Huang knows firsthand the effects of 
infectious diseases. Huang is from Taiwan, where  
Japanese encephalitis virus and dengue viruses are  
endemic pathogens.
“Once these viruses are introduced, there is no way to get 
rid of them because they can be persistent in mosquitoes 
or susceptible hosts,” said Huang, a university research 
assistant professor of diagnostic medicine and patho-
biology. “These viruses can infect humans and animals 
without showing symptoms, which makes them some of 
the hardest targets to control.”
That’s part of what motivates Huang to 
study mosquito-transmitted viruses at the 
university’s Biosecurity Research Institute, 
a biosafety level-3 facility where scientists 
can safely study animal and human  
infectious diseases. Higgs, Vanlandingham 
and Huang collaboratively are studying 
Zika virus, Japanese encephalitis virus, 
yellow fever virus and Cache Valley virus 
with researchers from institutions in the 
U.S. and the U.K.
The university scientists were part of a 
multi-institutional team that recently  
developed a possible new Zika virus  
vaccine and published the results in Na-
ture. The immunogenic vaccine potentially 
could protect against the virus with one 
dose and could become a tool to prevent 
future outbreaks, Higgs said. 
The Biosecurity Research Institute team 
played an important role during the Zika 
virus public health emergency in 2016. 
The institute has facilities needed to study mosquitoes 
and understand how they become infected with Zika 
virus.
Through a research project with Ross University, along 
with funding from the National Institutes of Health, the 
scientists are providing skills and expertise for further 
studies with Zika virus and chikungunya virus. 
But the university work extends to other emerging viruses 
as well. 
Higgs, Vanlandingham and Huang are performing several 
studies — funded by the National Bio and Agro-defense 
Facility Transition Fund and the Swine Health  
Information Center — on an emerging type of Japanese 
encephalitis virus. Their studies are the first U.S. studies 
of Japanese encephalitis since the 1940s and the researchers 
also are doing the first studies with the Cache Valley virus 
that is present in North America. 
Japanese encephalitis virus is found primarily in pigs and 
birds in Asia, but it can transmit to humans and cause 
severe inflammation, or encephalitis, of the brain. 
The Japanese encephalitis virus research at the Biosecurity 
Research Institute is especially important: A new,  
emerging type killed 14 people in China in 2014. Other 
older strains of Japanese encephalitis virus constantly are 
circulating in Asia and infect an estimated 67,900 people 
per year. Although many people in Asia are vaccinated, 
the vaccine is not very effective because it is made for the 
older strains, researchers said. 
“As the virus continues to circulate, the threat still 
remains,” Higgs said. “The new strain is just as bad as 
the old strain. If a strain is going to be introduced to the 
U.S., it’s going to be this new strain and the U.S. is not 
prepared for a potential outbreak.”
Through U.S. Department of Agriculture funding and 
collaboration with the Arthropod-Borne Animal Diseases 
Research Unit in Manhattan, the researchers are  
determining if North American mosquitoes could transmit 
Japanese encephalitis virus and how the U.S. could  
prevent an outbreak. 
The team has published results in Vector-Borne and  
Zoonotic Diseases and PLOS Neglected Tropical Diseases. 
The Japanese encephalitis virus work is a transition 
project that will jump-start research at the National Bio 
and Agro-defense Facility, or NBAF, the U.S. Department 
of Homeland Security’s foremost animal disease research 
facility that is being built adjacent to the university’s 
Manhattan campus.
Higgs, Vanlandingham and Huang’s research on Cache 
Valley virus aims to increase limited knowledge of the 
virus’s transmission cycles. The virus is an important 
agriculture pathogen that primarily affects sheep and is 
widespread in North America. 
With no approved vaccine or treatment, Cache Valley  
virus’s biggest human public health concern is its  
potential to cause neurotropic diseases, which can lead 
to permanent nerve damage, Huang said. The Biosecurity 
Research Institute work aims to identify potential carriers 
that could transmit Cache Valley virus. The USDA- 
sponsored project is a collaborative effort with U.K. 
researchers.
BACK TO THE BIOLOGICAL 
BASICS
One way to fight mosquito-borne diseases 
like malaria, yellow fever or dengue fever 
is to make the insect its own worst enemy. 
University biologist Kristin Michel has 
a specific target in mind: the mosquito 
immune system. 
Michel, associate professor of biology, 
and Bart Bryant, research assistant  
professor of biology, are studying  
Anopheles gambiae, the mosquito species 
that is the main transmitter of malaria 
in sub-Saharan Africa. Their goal is to 
identify ways to eliminate pathogens and 
parasites in the mosquito before it can 
transmit them to humans. 
Michel and Bryant approach their work 
like a puzzle: Figure out what molecules 
are in the immune system, how they 
function and what immune responses they 
control. Then determine how these pieces fit together to 
contribute to the mosquitoes’ immunity as a whole and 
how they relate to the pathogen.
Their NIH- and USDA-funded research has determined 
the key role of proteases and their inhibitors in controlling 
humoral immunity as well as the role of hemocytes in 
cellular immunity. 
Michel’s team recently showed that in the first 24 hours 
after a mosquito eats, the hemocytes — or blood cells — 
increase in a mosquito’s immune system as it prepares to 
fight any pathogens from the blood.
“Imagine if every single time you eat a meal, all your 
white blood cells double,” Michel said. “It would have 
to be a massive infection or inflammation response, and 
mosquitoes do that every time they take a blood meal.”
Bryant now is using NIH funding to develop a gene  
therapy-type approach to turn off specific genes in  
specific tissues in Anopheles gambiae.
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“We want to better understand what a gene is doing and what its role is 
in one tissue versus another,” Bryant said. “We’re trying to come up with 
a unique way to better regulate the expression of a gene.”
A better genetic understanding could help stop the spread of malaria, 
yellow fever and dengue fever. Scientists could maximize mosquito  
control strategies while minimizing side effects for the insect. 
“Malaria is a global problem,” Michel said. “People agree that the 
existing control methods will not lead to elimination of malaria. We 
need to accelerate our efforts and for that, we need to continue to do 
research. Our team wants to contribute — even if it’s a tiny bit — to that 
mission.” 
GOING WITH THE GUT
Only a few dozen of the more than 3,000 species of mosquitoes in the 
world can transmit viruses. To understand why, two biology professors 
— Rollie Clem and Lorena Passarelli — are investigating the insects’ 
intestines.
It turns out that the gut and the surrounding structure — called the 
basal lamina — are a mosquito’s key defense against viruses. Through 
NIH funding, Clem and Passarelli have studied the basal lamina and its 
network of proteins to understand how it can act as a barrier against 
viruses and how that barrier is disrupted during a blood meal. 
When a mosquito bites a host, any viruses in the blood travel through 
the mosquito digestive system to the gut. Sometimes viruses are able to 
escape the gut, infect the salivary glands and shed in the saliva when the 
mosquito bites another host. Yet other times, viruses are not able to leave 
the gut and the mosquito does not spread the virus. The biologists want 
to know how the virus can escape the gut and travel into the main body. 
“We previously identified enzymes that were necessary for midgut escape 
in an insect virus,” Passarelli said. “We are now investigating whether 
mosquito-vectored viruses use the same enzymes to facilitate midgut 
escape.” 
Specifically, the researchers are studying Sindbis virus, a mosquito- 
transmitted virus that can cause mild symptoms in humans, such as fever 
or a rash. The biologists use an arthropod containment level-2 facility to 
safely study Aedes aegypti mosquitoes.
By looking at enzymes involved in allowing midgut escape by Sindbis 
virus, the researchers could apply any gained knowledge to other Aedes 
aegypti-transmitted diseases, including Zika virus, dengue fever and 
yellow fever.
“Many of these diseases are in other countries, but certainly are  
threatening to come into the U.S.,” Clem said. “With changing climates, 
these mosquitoes are expanding their range farther and farther north. 
There is a lot of public awareness about the importance of these diseases 
and our research could help the millions of people affected by these 
viruses every year.” 
INVESTIGATING INSECT CONTROL 
Of course, a key way to keep mosquito-borne diseases under control is 
to control the insects that spread them.
That’s where Kun Yan Zhu, professor of entomology, fits in. His work 
starts with chitin, a major chemical component of a mosquito’s  
exoskeleton shield. When insects are not able to produce chitin, they 
can’t survive. But when insects produce a reduced amount of chitin, they 
may become more susceptible to insecticides.
“The exoskeleton is the first defense line for mosquitoes and other 
insects,” Zhu said. “Chitin biosynthesis is an important target for insect 
control. We are trying to understand chitin biosynthetic pathways and 
develop new techniques to prevent chitin production using chemical and 
genetic approaches.”
Zhu and his team recently patented a form of nanoparticle insect control 
that uses a genetic chain reaction to prevent mosquitoes and insects from 
producing chitin. 
“Insect control that targets chitin biosynthesis is safer and less likely to 
affect humans because we do not produce chitin,” Zhu said.
Zhu’s research also is attacking another major problem in mosquito  
control: insect resistance to insecticides. Over time, mosquitoes can 
become resistant to insecticides, which have to be replaced with newer 
versions.
Using USDA and other funding, his team is investigating a family of  
enzymes that helps mosquitoes detoxify chemicals. The scientists are  
trying to find possible connections between the insecticide structure and 
the detoxification enzymes in Aedes aegypti mosquitoes to better  
understand how the mosquitoes become insecticide-resistant.
“By understanding detoxification mechanisms, we will be able to  
selectively use insecticides that may be able to control resistant insects,  
including mosquitoes,” Zhu said. “This is an important strategy to  
control some of the most devastating disease-spreading insects in the 
world.”
















JAPANESE ENCEPHALITIS VIRUS 
Japanese encephalitis virus is Asia’s leading 
cause of pediatric viral encephalitis, or 
severe inflammation of the brain. While most 
human cases are mild, about 1 in 4 unvacci-
nated human cases are fatal.  
A CLOSER LOOK AT MOSQUITO-BORNE DISEASES 
CACHE VALLEY VIRUS 
Cache Valley virus comes from the northern 
agricultural valley in Utah with the same 
name. While it primarily affects sheep and 
rarely infects humans, severe cases can cause 
brain inflammation or organ failure.
ZIKA VIRUS
Zika virus detections have occurred since 
the 1940s, but an epidemic spread through 
the Americas in 2015-2016. Many humans 
infected only have mild symptoms, but the 
virus is linked to birth defects, including 
microcephaly.   
MALARIA
Malaria is a severe and potentially fatal  
disease found in warmer regions. It can 
cause high fevers, chills and flu-like symp-
toms. Young children and pregnant women 
are most vulnerable.    
CHIKUNGUNYA VIRUS 
Chikungunya fever first appeared in the 
1950s, but the first transmission in the 
Americas occurred in 2013 on Caribbean 
islands. Chikungunya virus is not often fatal, 
but can cause fever, muscle pain, headaches 
and severe joint pain in humans.  
DENGUE FEVER VIRUSES 
Dengue fever is the main cause of illness and 
death in tropical and subtropical regions. It 
can cause high fevers, joint pain and mild 
bleeding. Dengue hemorrhagic fever is a 
severe form that can be fatal if untreated. 
WEST NILE VIRUS 
West Nile virus came to North America in 
1999 and has become endemic in the U.S. 
and Canada. Only 1 in 5 people infected 
develop symptoms. Severe cases can lead to 
encephalitis or meningitis, while rare cases 
cause a fatal neurologic illness.
YELLOW FEVER VIRUS 
Yellow fever can produce devastating 
outbreaks in tropical regions. Most infected 
people have only mild illness, but severe cases 
can cause liver disease and bleeding. Fatalities 
occur in 20 to 50 percent of severe cases. 
Sources: Centers for Disease Control and Prevention, World Health Organization
INSIDE A SWARM
What is it like to be in the middle 
of a swarm of mosquitoes? Check 
out an interactive 360-degree video 
and photo that show a closer look at 






Anopheles gambiae mosquitoBart Bryant  and lead 
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Learn more about 
these diseases at 
k-state.edu/seek/mosquito. 
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